
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270222
DTEND;VALUE=DATE:20270225
DTSTAMP:20260923T123621Z
CREATED:20260923T123544Z
LAST-MODIFIED:20260923T123621Z
UID:10001062-1803254400-1803513599@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies (TAT) Congress 2027
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2027 will take place from February 22–24\, 2027\, at the Palais des Congrès de Paris in Paris\, France. \nOrganized by the European Society for Medical Oncology (ESMO)\, the congress will bring together clinicians\, researchers\, and experts in drug development to discuss advances in early-phase oncology research and innovative anticancer therapies. \nThe meeting will focus on the development and clinical translation of targeted anticancer therapies\, including molecularly driven drug development\, precision oncology approaches\, biomarkers\, early clinical trials\, and emerging treatment strategies. The congress provides a platform for researchers\, clinicians\, and industry experts to exchange knowledge on new therapeutic approaches and their path from discovery to patient care.
URL:https://oncodaily.com/event/targeted-anticancer-therapies-591846
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-23-2026-04_34_52-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR